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The purpose of the study was to draw upan experimental model of hepatic
veno-occlusive disease (VOD) induced by dactinomycin (ACT) and to investigate
the possible hepatoprotective effects of Ethyol (amifostine). Pathological chang-
es corresponding to a VOD picture of varying intensification were found in the
liver samples obtained from all the rats receiving ACT. Amifostine appears to act
protectively to liver changes caused by dactinomycin.
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INTRODUCTION
A new complication following chemotherapy has
been observed in recent years during bone marrow
transplantation [1] and treatment for nephroblas-
toma [2, 5], namely liver veno-occlusive disease or
VOD. This term was established by Bras in 1954.
Veno-occlusive liver disease was first reported from
the populations of Central America and Asia who
drank herbal tea which contained vegetal alkaloids
[1]. It can also be induced by drugs, including anti-
neoplastic antibiotics such as ACT used to treat
nephroblastoma. The clinical criteria of VOD have
been established [4]. These are hepatomegaly, as-
cites and/or weight increment, jaundice caused by
hepatocyte necrosic and damage to the venous en-
dothelium and intrahepatic sinuses [6].
MATERIAL AND METHODS
The study used 40 male Wistar rats divided into
a control group and two experimental groups. The
animals of the experimental group (group I) received
dactinomycin (ACT) intraperitoneally 3 times (d 1–3),
each separated by a week, in a dose of 15 mcg/kg
b.w. Group II rats were given ACT + amifostine
15 min before the last ACT dose. The control ani-
mals received 0.9% solution of physiological saline.
Liver specimens were collected in narcosis with ket-
amine on day 7 after the last ACT injection. The
material was fixed in 10% formalin and in Gandre’s
fluid. Paraffin sections were stained with haema-
toxylin and eosin (H + E). The PAS method of stain-
ing for argyrophilic fibres according to Gomori and
the electron microscope technique were used.
RESULTS AND DISCUSSION
Liver preparation of the control animals showed
a normal histological pattern. The cytoplasm of mul-
tilateral hepatocytes stained with haematoxylin and
eosin contained fine eosinophilic granules (Fig. 1).
Staining with the PAS method showed a high but
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varied glycogen content in the cells. A small num-
ber of argyrophilic fibres were observed in the wall
of the central veins and sinusoids when using the
Gomori method. The liver preparations obtained
from the animals receiving dactinomycin showed
the following changes: hepatic trabecular diasta-
sis, vacuolar degeneration of the hepatocytes and
high differentiation of the cellular nuclei — in most
cases they were hyperchromatic and had irregular
contours (Fig. 2). In all the experimental animals
thrombotic and deliquescent necrosis was found
mainly in the central part of the lobules. Moreover,
the walls of the central veins were thickened. The
sinuses contained numerous erythrocytes and small
platelet thrombi, as well as a large number of fi-
broblasts around the vessels. The preparations
stained with the PAS method had low glycogen
content or none at all in the necrotic cells. The num-
ber of argyrophilic fibres increased, which was re-
vealed by the Gomori method (Fig. 3). These mor-
phological changes correspond to veno-occlusive
liver disease and are similar to those described by
other authors [4, 6]. The VOD symptoms were con-
firmed by electron microscopy. Damage to the mi-
tochondria included swelling, the occurrence of
megamitochondria, dilation of the rough endoplas-
mic reticulum channels and accumulation of col-
lagen fibres (Fig. 4). The liver of animals receiving
ACT with amifostine showed much less intensified
pathomorphological changes. The morphological
picture in the light and electron microscope resem-
bled that of the control rats (Fig. 5). Amifostine
has a wide protective spectrum [3]. Moreover, it
reaches a high level of concentration in hepatic tis-
sue [3, 7]. Its protective action against the harmful
effects of chemotherapy has been proved [7]. The
neutral pH of the cells promotes greater activity by
the alkaline phosphatase and amifostin transport
to the cell. The active metabolite of amifostine pre-
vents the binding of cytostatics with cellular DNA,
thus stabilising its chemical bindings and prevent-
ing it from destruction. It also reduces cell apopto-
sis induced by chemical substances. Irrespective of
the protective mechanism it can be concluded that
amifostine exerts a protective effect against hepa-
totoxic ACT action.
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